BACKGROUND: An optimal management of maternal @entity1378 is important for positive pregnancy outcome, and to this end, the Endocrine Society published their guidelines in 2007. This survey aimed to investigate to what extent the clinical practice relating to the management of @entity1378 during pregnancy in Europe is uniform and consistent with the guidelines. MATERIALS AND METHODS: We e-mailed an online questionnaire survey based on clinical case scenarios to 605 members of the European Thyroid Association. We analysed 190 responses from 28 European countries. RESULTS: For a @entity1 with newly diagnosed @entity2743 ( @entity2743 ) and wishing pregnancy, 78% of the responders would initiate antithyroid drugs (ATDs), while 22% would recommend definitive treatment with radioiodine or surgery. In case of a relapsed @entity2743 before pregnancy, 80% preferred definitive treatment. For a @entity1 with newly diagnosed @entity2743 during pregnancy, 53% would treat with @entity5652 , 12% with @entity3937 , and 34% with @entity5652 initially and switch to @entity3937 after the first trimester. Responders used several combinations of tests to monitor the dose of ATDs, and the thyroid test results they targeted were inconsistent. For a lactating @entity1 with @entity2743 , 68% would give ATDs without stopping lactation. CONCLUSIONS: Variation in the clinical practices surrounding the management of @entity1378 pregnant @entity1 in Europe still exists.

Management of XXXX in Pregnancy: Results of a Survey among Members of the European Thyroid Association.

@entity1 :: ('9606', 'Species') :: ['women', 'woman'] @entity3937 :: ('MESH:D008713', 'Chemical') :: ['methimazole'] @entity2743 :: ('MESH:D006111', 'Disease') :: ["Graves' disease", 'GD'] @entity1378 :: ('MESH:D006980', 'Disease') :: ['hyperthyroidism', 'hyperthyroid'] @entity5652 :: ('MESH:D011441', 'Chemical') :: ['propylthiouracil']
@entity1378 :: (MESH:D006980,Disease) :: ['Hyperthyroidism']
